Cibc Private Wealth Group, LLC Axsome Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 13,715 shares of AXSM stock, worth $1.86 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,715
Previous 16,214
15.41%
Holding current value
$1.86 Million
Previous $1.37 Million
16.63%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AXSM
# of Institutions
412Shares Held
37.4MCall Options Held
710KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$536 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$448 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$229 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$206 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$154 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.82B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...